Researcher
Kathleen Machiels
- Disciplines:Endocrinology and metabolic diseases, Gastro-enterology and hepatology, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Translational Research in GastroIntestinal Disorders (Division)
Member
From1 Aug 2009 → 3 Jan 2022
Projects
1 - 6 of 6
- CHARM: CHAracterization and ReMediation of a dysbiotic colon microbiota configurationFrom1 Jan 2020 → 31 Dec 2023Funding: FWO research project
- Microbiota modulation strategies in Inflammatory Bowel Disease managementFrom1 Oct 2019 → 1 Oct 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Fecal microbiota transplant in ulcerative colitis patients: what is the role of the human gut virome and can it be used as a biomarker for predicting treatment succesFrom1 Oct 2018 → 31 May 2023Funding: FWO Strategic Basic Research Grant
- Therapeutic manipulation of the gut microbiome in inflammatory bowel diseaseFrom1 Aug 2016 → 9 Dec 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Fecal microbiota transplantation in patients with ulcerative colitis: fecal donor selection and interplay between intestinal microbiota, diet and host geneticsFrom1 Jan 2016 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
- Functional, temporal and spatial variability of the intestinal microbiome in the pathogenesis of inflammatory bowel disease.From1 Oct 2014 → 3 Jan 2021Funding: FWO fellowships
Publications
1 - 10 of 45
- Therapeutic manipulation of the gut microbiome in inflammatory bowel disease(2021)
Authors: Clara Caenepeel, Séverine Vermeire, Jeroen Raes, Kathleen Machiels
- Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?(2021)
Authors: Sara Deleu, Kathleen Machiels, Jeroen Raes, Kristin Verbeke, Séverine Vermeire
- Fungal and Bacterial Loads: Noninvasive Inflammatory Bowel Disease Biomarkers for the Clinical Setting(2021)
Authors: Kathleen Machiels, Séverine Vermeire
- Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease(2021)
Authors: Sare Verstockt, Bram Verstockt, Kathleen Machiels, Marc Ferrante, Isabelle Cleynen, Gert De Hertogh, Séverine Vermeire
Pages: 1564 - 1575 - Early Postoperative Endoscopic Recurrence in Crohn's Disease Is Characterised by Distinct Microbiota Recolonisation(2020)
Authors: Kathleen Machiels, João Guedelha Sabino, Albert Wolthuis, Gert De Hertogh, Marc Ferrante, Séverine Vermeire
Pages: 1535 - 1546 - Mucosal microbial load in Crohn's disease: A potential predictor of response to faecal microbiota transplantation(2020)
Authors: Kathleen Machiels, Séverine Vermeire
- Gene and Mirna Regulatory Networks During Different Stages of Crohn's Disease(2019)
Authors: Sare Verstockt, Gert De Hertogh, Bram Verstockt, Kathleen Machiels, Frans Schuit, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ingrid Arijs, Isabelle Cleynen
Pages: 916 - 930 - Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades(2019)
Authors: Annick Moens, Bram Verstockt, Kathleen Machiels, Peter Bossuyt, Katrien Lagrou, Gert Van Assche, Séverine Vermeire, Marc Ferrante
Pages: 668 - 673 - SERUM PROTEOMIC PROFILING IN ULCERATIVE COLITIS PATIENTS UNDERGOING ILEOANAL POUCH SURGERY REVEALS PREDICTIVE AND DIAGNOSTIC MARKERS FOR POUCHITIS(2019)
Authors: Kathleen Machiels, Marc Ferrante, Nooshin Ardeshir Davani, Albert Wolthuis, André D'Hoore, Séverine Vermeire
Pages: S22 - S22 - SERUM PROTEOMIC PROFILING REVEALS CHANGES IN INFLAMMATORY PROFILES WITH CONSECUTIVE BIOLOGICAL THERAPIES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE(2018)
Authors: Sare Verstockt, Bram Verstockt, Gert Van Assche, Marc Ferrante, Kathleen Machiels, Séverine Vermeire
Pages: S1023 - S1023